Columbia Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Columbia Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-90,000	Closed	-$90.6K	–	179
2025 Q1	$90.6K	Sell	90,000 -20,000	-18%	-$1.17M	0.02%	212
2024 Q4	$110K	Buy	+110,000	New	+$6.15M	0.02%	222

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Columbia Asset Management's BMY Position: Q2 2026 in Review

Columbia Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,425 shares worth $313K. The position accounts for 0.05% of the portfolio, ranked #141.

Columbia Asset Management first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.28M in Q2 2016. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Columbia Asset Management held 5,425 shares of Bristol-Myers Squibb worth $313K as of Q2 2026.
Columbia Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.05% of Columbia Asset Management's portfolio in Q2 2026, its #141 holding.
Columbia Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
Columbia Asset Management's Bristol-Myers Squibb position peaked at $1.28M in Q2 2016.
1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.